论文部分内容阅读
To the Editor:Current treatment guidelines for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) recommend dual antiplatelet therapy,a combination of aspirin and a P2Y12 inhibitor (i.e.,clopidogrel,prasugrel,and ticagrelor) for a minimum of 12 months.